Journal profile · Pharmacology & Pharmacy
Pharmacological Reports
ISSN 1734-1140 · eISSN 2299-5684 · Springer International Publishing · POLAND · Bimonthly · Founded 2009
Pharmacological Reports: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 4.45; hybrid open access; APC about USD 3,290; median 98 days to acceptance (109 articles, last 24 months); community-reported acceptance: fairly easy; 126 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Pharmacological Reports is published by Springer International Publishing and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Neuroscience and Neuropharmacology Research, Neurotransmitter Receptor Influence on Behavior and Tryptophan and brain disorders, together about 30.7% of its articles. Its main subfields are Cellular and Molecular Neuroscience. (generated from OpenAlex topic counts and CAS ranking data)
Pharmacological Reports is the official journal of Maj Institute of Pharmacology Polish Academy of Sciences.Pharmacological Reports is an open forum for recent developments in experimental and clinical pharmacology, dealing with the action of drugs at cellular, molecular and behavioral levels.It publishes research articles, reviews, and short communications. The journal guarantees rapid publication of accepted papers, comprised of fast acceptance and publication for articles. It is a hybrid journal, offering the choice of open access, and is published bi-monthly.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Katarzyna FijałPublisher website
Editorial board by country: none in mainland China; most named Poland 31, Italy 3, United States 2, United Kingdom 1, Germany 1 (41 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Neuroscience and Neuropharmacology ResearchNeuroscience12.4%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience10%
- Tryptophan and brain disordersNeuroscience8.3%
- Stress Responses and CortisolNeuroscience5.8%
- Pain Mechanisms and TreatmentsMedicine5.7%
- Neuropeptides and Animal PhysiologyNeuroscience5.5%
- Pharmacological Effects and Toxicity StudiesMedicine4.7%
- Epilepsy research and treatmentMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.45LetPub ·
- Impact factor (publisher) 2025
- 4.5Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.2Publisher website ·
- CiteScore 2026-06
- 7.2LetPub ·
- SJR 2026-06
- 1.02LetPub ·
- SNIP 2026-06
- 0.99LetPub ·
- h-index
- 71LetPub ·
- h-index
- 99OpenAlex ·
- i10-index
- 1,720OpenAlex ·
- 2-year mean citedness
- 4.16OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 51.14%LetPub ·
Volume
- Articles per year
- 120LetPub ·
- Downloads per year (publisher) 2025
- 709,300Publisher website ·
Articles by year OpenAlex count · 3,747 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 94 | 60 | 37 |
| 2025 | 126 | 70 | 492 |
| 2024 | 127 | 79 | 914 |
| 2023 | 116 | 68 | 1,853 |
| 2022 | 102 | 54 | 1,608 |
| 2021 | 144 | 86 | 3,207 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
98 daysMedian, submission to acceptance · P25–P75 75 days – 140 days
- Acceptance to online
- median 13 days (109 articles)
- Submission to online
- median 113 days
- Sample
- 109 articles with submission and acceptance dates (249 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 6 monthsLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 5 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,290 / EUR 2,690 / GBP 2,390 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access publishing
Open access publishing information (fees, funding, licences) is available on the Open access publishing page. Model summary
To find out more about publishing your work Open Access in Pharmacological Reports, including information on fees, funding and licences, visit our Open access publishing page.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer International Publishing
- Country or region
- POLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2009
- ISSN
- 1734-1140
- Electronic ISSN
- 2299-5684
- Society / sponsor
- Maj Institute of Pharmacology Polish Academy of Sciences
- Latest issue on the website
- Volume 78, Issue 4 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Pharmacological Reports
What CAS zone is Pharmacological Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pharmacological Reports is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pharmacological Reports?
The latest impact factor listed by LetPub is 4.45; CiteScore 7.2, h-index 99.
How long does peer review take at Pharmacological Reports?
Based on the dates recorded on 109 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 98 days (interquartile range 75–140 days); authors report an average review time of about 6 months; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Pharmacological Reports based?
Of the 41 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Poland (31), Italy (3) and United States (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Pharmacological Reports?
According to LetPub and DOAJ records, Pharmacological Reports is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Pharmacological Reports open access, and what is the APC?
Pharmacological Reports is a hybrid journal. For open-access publication: APC about USD 3,290.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .